title: Efficacies of biological therapies at week 12 in patients with plaque psoriasis in real-world academic clinical practice: a Canadian multicentre retrospective study.
authors.affiliation: School of Medicine, University of Ottawa, Ottawa, ON, Canada.
authors.forename: A
authors.initials: A
authors.lastname: Shahbaz
authors.affiliation: School of Medicine, University of Ottawa, Ottawa, ON, Canada.
authors.forename: J
authors.initials: J
authors.lastname: Qiang
authors.affiliation: Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada.
authors.forename: J E C
authors.initials: JEC
authors.lastname: Marinas
authors.affiliation: Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada.
authors.forename: W B
authors.initials: WB
authors.lastname: Kim
authors.affiliation: Department of Statistical Sciences, University of Toronto, Toronto, ON, Canada.
authors.forename: S
authors.initials: S
authors.lastname: Greaves
authors.affiliation: Division of Dermatology, Department of Medicine, University of Toronto, Toronto, ON, Canada.|Sunnybrook Health Sciences Centre, Toronto, ON, Canada.|Women's College Hospital, Toronto, ON, Canada.
authors.forename: J
authors.initials: J
authors.lastname: Yeung
mesh_terms: D000068879:Adalimumab / Q000627:therapeutic use; D000328:Adult; D001688:Biological Products / Q000627:therapeutic use*; D001691:Biological Therapy / Q000379:methods*; D002170:Canada; D003879:Dermatologic Agents / Q000627:therapeutic use*; D000068800:Etanercept / Q000627:therapeutic use; D005260:Female; D006801:Humans; D000069285:Infliximab / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D011565:Psoriasis / Q000188:drug therapy*; D012189:Retrospective Studies; D016896:Treatment Outcome; D000069549:Ustekinumab / Q000627:therapeutic use
chemical_list: D001688:Biological Products; D003879:Dermatologic Agents; D000069285:Infliximab; D000069549:Ustekinumab; D000068879:Adalimumab; D000068800:Etanercept